Community observations, not medical advice.Always speak with a qualified healthcare professional.
supplement

L-Tyrosine

Also known as L-Tyrosine, N-Acetyl-L-Tyrosine

Non-essential amino acid and precursor to dopamine and noradrenaline via the enzyme tyrosine hydroxylase; most consistent evidence is for preserving cognitive performance under acute stress, sleep loss, or cold exposure rather than baseline mood.

Be careful if: pregnant, breastfeeding, certain health conditions

Suspect a side effect? Report it to the MHRA Yellow Card scheme ↗

3linked conditions
22linked studies
Evidence

What the research actually shows

We link to relevant studies and leave interpretation to you and your healthcare professional.

Safety

Safety and considerations

What sources report about side effects, who should be careful, and medicines to ask about first.

Be careful if you…

Applies toWhat sources saySources
pregnantNo pregnancy safety guidance found in any chain source checked (no UK SmPC, BNF/NICE, NHS, NIH ODS or EMA HMPC entry exists for L-tyrosine); the reviewed trials report no pregnancy data. Not studied in pregnancy — assume nothing and ask a clinician.Jongkees BJ, et al. Effect of tyrosine supplementation on clinical and healthy populations under stress or cognitive demands — a review. J Psychiatr Res 2015;70:50-7 (PMID 26424423)
breastfeedingNo breastfeeding safety guidance found in any chain source checked (no UK SmPC, BNF/NICE, NHS, NIH ODS or EMA HMPC entry exists for L-tyrosine); no lactation data in the reviewed trials. Not studied while breastfeeding — assume nothing and ask a clinician.Jongkees BJ, et al. Effect of tyrosine supplementation on clinical and healthy populations under stress or cognitive demands — a review. J Psychiatr Res 2015;70:50-7 (PMID 26424423)
certain health conditionsPhenylketonuria: people with PKU are under specialist dietary management, and a Cochrane review found insufficient evidence to recommend routine tyrosine supplementation in PKU. Any use should go through their metabolic team.Webster D, Wildgoose J. Tyrosine supplementation for phenylketonuria. Cochrane Database Syst Rev 2010;(8):CD001507 (PMID 20687067)

Suggested uses (unproven)

Where people report using it and what trials suggest

  • Moderate evidenceCognitive resilience under acute stress (military/lab cold, sleep dep)

Where the evidence is negative

Common claims the trials do not support

  • No benefit in rested, unstressed people.
  • Depression trials (old) failed vs imipramine/placebo.
  • Does not boost baseline attention or mood.

Catecholamine-precursor amino acid with specific evidence for cognition under acute, real stress (cold, sleep loss, multitasking) — not an everyday focus pill.

Evidence grades reflect study quality and consistency, not marketing claims.

22studies referenced
17journals
2003–2025publication range

Ordered by strength of evidence, then result direction.

01Levodopa and Plant-Derived Bioactive Compounds in Parkinson's Disease: Mechanisms, Efficacy, and Future PerspectivesAktaş E, et al. · CNS neuroscience & therapeutics · 2025PMID 40808332 ↗02Neurochemical and genetic factors in panic disorder: a systematic reviewMoraes ACN, et al. · Translational psychiatry · 2024PMID 39025836 ↗03Verbascoside: A neuroprotective phenylethanoid glycosides with anti-depressive propertiesZhao Y, et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2023PMID 37657207 ↗04The potential role of nutritional components in improving brain function among patients with Alzheimers disease: a meta-analysis of RCT studiesAlbrahim T · Neurosciences (Riyadh, Saudi Arabia) · 2020PMID 31982903 ↗05Epigenetic meta-analysis across three civilian cohorts identifies NRG1 and HGS as blood-based biomarkers for post-traumatic stress disorderUddin M, et al. · Epigenomics · 2018PMID 30456986 ↗06Stress, burnout and depression: A systematic review on DNA methylation mechanismsBakusic J, et al. · Journal of psychosomatic research · 2017PMID 27998510 ↗
Show all 22 studies
07An updated meta-analysis of oxidative stress markers in bipolar disorderBrown NC, et al. · Psychiatry research · 2014PMID 24794031 ↗08Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine TumorsChan JA, et al. · The New England journal of medicine · 2025PMID 39282913 ↗09Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 studyKuter DJ, et al. · Blood · 2025PMID 40090011 ↗10Randomized controlled trial evaluating synbiotic supplementation as an adjuvant therapy in the treatment of Parkinson's diseaseRamadan ME, et al. · Inflammopharmacology · 2025PMID 40434674 ↗11Nonclinical and Clinical Assessments of an Optimized Tablet Formulation of the Novel HER2-Selective Tyrosine Kinase Inhibitor Zongertinib: Focus on Relative Bioavailability and Impact of Variation of Gastric pHWölke S, et al. · Molecular pharmaceutics · 2025PMID 41060706 ↗12Impact of L-theanine and L-tyrosine on markers of stress and cognitive performance in response to a virtual reality based active shooter training drillMcAllister MJ, et al. · Stress (Amsterdam, Netherlands) · 2024PMID 38975711 ↗13Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trialAndré F, et al. · Lancet (London, England) · 2023PMID 37086745 ↗14Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trialRugo HS, et al. · Lancet (London, England) · 2023PMID 37633306 ↗15Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trialBidard FC, et al. · The Lancet. Oncology · 2022PMID 36183733 ↗16Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast CancerMurthy RK, et al. · The New England journal of medicine · 2020PMID 31825569 ↗17Lactobacillus plantarum DR7 alleviates stress and anxiety in adults: a randomised, double-blind, placebo-controlled studyChong HX, et al. · Beneficial microbes · 2019PMID 30882244 ↗18MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine TherapySledge GW Jr, et al. · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2017PMID 28580882 ↗19Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trialChoueiri TK, et al. · The Lancet. Oncology · 2016PMID 27279544 ↗20Palbociclib in Hormone-Receptor-Positive Advanced Breast CancerTurner NC, et al. · The New England journal of medicine · 2015PMID 26030518 ↗21Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trialvan der Graaf WT, et al. · Lancet (London, England) · 2012PMID 22595799 ↗22Nutritional evaluation of protein hydrolysate formulas in healthy term infants: plasma amino acids, hematology, and trace elementsHernell O, et al. · The American journal of clinical nutrition · 2003PMID 12885712 ↗

Published research summaries are unavailable.

Outcomes & conditions

Why people look into L-Tyrosine — and what they report

Associated conditions and community-reported outcomes, wrapped together on one page. Aggregates appear only once enough reports arrive.

Outcomes & conditions →
Important: This page reflects observational, aggregate-only community reporting and independent published research. It is not medical advice, and it does not claim any compound treats, cures, or is effective for any condition. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or treatment.
Availability

Where to get L-Tyrosine (UK)

How this compound is sold in the UK, and where our readers typically find it.

Retailer search links — we may earn commission on purchases at no cost to you. Commission never affects our evidence ratings.

Search L-Tyrosine on Amazon UK →Search L-Tyrosine on Holland & Barrett →Search L-Tyrosine on iHerb →